Don’t punt on your CBS shares just because professional football ratings are down this season. The media giant’s digital initiatives and steady diet of share buybacks will help the stock over the long-term, said Erin Gibbs, portfolio manager at S&P Investment Advisory Services. “CBS is seeing increasing revenues, margins and earnings. The Wall Street consensus estimate is for long term earnings per share growth of 19%,” said Gibbs. “Meanwhile, the stock is trading at 13 times its forward earnings, well below its three year average, as well as that of the sector.” Shares of CBS are up 18% thus far in 2016. Gibbs is also bullish on Constellation Brands , up 17% year-to-date, saying its recent acquisitions are supporting growth in both the beer and wine segments. The stock is trading at 23 times its forward earnings, higher than the sector’s average of 20, but Constellation has significantly higher growth. Monsanto , up 3% year-to-date, is another one of Gibbs’ top picks. Bayer AG offered $128 per share to acquire Monsanto last month. There are many regulatory hurdles and it is expected that the companies will have to shed some businesses for approval. But it is expected to be approved and contribute to higher margins. “Either you make money from the Bayer merger if it gets completed or you are looking at 9% growth and the leader in GMO technology. So it’s a win/win situation,” said Gibbs. ” Finally, Gibbs is a fan of healthcare provider Aetna , up 3% year-to-date. The stock has taken a beating now that it looks unlikely that the Humana deal will be approved. And Aetna would owe Humana a $1 billion breakup fee due to an antitrust termination. Plus, every time healthcare is brought up in the election, healthcare stocks take another beating. But in spite of the merger rejection and headlines, Aetna looks extremely well valued, according to Gibbs. “We don’t think the deal is going to get done but the headline risk is creating a cheap stock in the meantime,” said Gibbs.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
